Nisrine Bissar

Nisrine Bissar

Auto-generated profile, based on publicly available information

Nisrine Bissar

Beirut Arab University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2026 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
NBNisrine Bissar
Nisrine Bissar
RKRayan Kassir
Rayan Kassir
FMFerdos Missilmani
Ferdos Missilmani
ESElie Salem Sokhn
Elie Salem Sokhn
Said El ShamiehSaid El Shamieh
Said El Shamieh
Background: Alzheimer's disease (AD) is a progressive neurodegenerative characterized by amyloid-β (Aβ) peptide aggregation and tangles. Protein translation deregulation and viral exposures, including SARS-CoV-2, have been implicated in increased AD risk. Genes such as YIF1A, PABPC4, and MRPS27, which are involved in mRNA translation and protein folding have been linked to neurodegeneration and host responses to SARS-CoV-2. Objective: This study investigates the association of three genetic variants, rs7945723G>A , rs6587A>G, and rs6831A>G, respectively correlated with YIF1A , PABPC4, and MRPS27 , with AD, and explored their expression in COVID-19 samples to assess potential shared pathways. Methods: A KASP genotyping assay was performed on 127 AD patients and 250 controls. A Binary logistic regression model assessed the association between AD and the single nucleotide polymorphisms, adjusting for age, sex, body mass index, and education. Gene expression was quantified by RT-qPCR in nasopharyngeal samples from 32 COVID-19 patients and 39 controls. The Mann- Whitney test compared gene expression between groups, and logistic regression evaluated associations with COVID-19 status. Results: Results showed that rs6587A>G in PABPC4 is significantly associated with AD risk with the GG genotype conferring increased susceptibility (OR = 4.3, p = 0.010). Gene expression analysis revealed no significant differences in PABPC4 , YIF1A , or MRPS27 between COVID-19 and control groups. Conclusions: Our findings suggest that post-transcriptional regulatory mechanisms, particularly involving PABPC4, may contribute to AD-related pathways. Larger multi-ethnic cohorts and functional studies are needed to clarify the role of PABPC4 and potential shared mechanisms between AD and COVID-19.

30 April 2022 in BAU Journal - Health and Well-Being
Verified
Journal Article
Closed access
PDF file
ZEZeina El-Ali
Zeina El-Ali
MZM Fouad M Ziade
M Fouad M Ziade
Hassan ZmerlyHassan Zmerly
Hassan Zmerly
NBNisrine Bissar
Nisrine Bissar
To investigate the effect Interleukin-16 (IL-16) and Interleukin-10 (IL-10) polymorphisms, and their interaction, on knee osteoarthritis (KOA) risk in the Lebanese population. Kompetitive Allele Specific PCR (KASP) genotyping assay was performed to determine IL-16 rs4778889, rs11556218, and rs4072111 and IL-10 rs1800896 polymorphisms in 118 patients diagnosed with KOA ( ≥ 2 points on Kellgren-Lawrence (K&L) radiological classification scale) and 70 controls matched for age and gender (K&L score ≤ 1). After adjusting for age, gender, presence of metabolic disorders, smoking and drinking status, our findings suggest that rs4778889 TT genotype increases the risk for KOA compared to the combined CC and TC genotypes (OR=2.131, 95% CI 1.037 – 4.379, p = 0.04) and that the T allele increases KOA risk compared to the C allele (OR=1.8, 95% CI 1.008 – 3.212, p = 0.047). No significant associations with the disease risk were found for the other studied polymorphisms (p > 0.05). Our data suggest that there is an interaction between IL-16 rs4778889 and IL-10 rs1800896 (p = 0.010). IL-16 rs4778889 TT genotype increases the risk for KOA only among individuals carrying IL-10 rs1800896 GG or GA genotypes (OR=4.821, 95% CI 1.847 – 12.583). None of the IL-16 haplotypes was associated with KOA risk in our study population (p > 0.05). Our findings suggest that IL-16 rs4778889 T allele is associated with KOA and that there is an interaction between this polymorphism and IL-10 rs1800896 with regard to KOA.